DAB2IP and chronic obstructive pulmonary disease: Finally, we observed similar levels of DAB2IP immunoreactivity in bronchial epithelial cells of smokers, COPD ex-smokers and COPD smokers, while the levels of EZH2 and H3K27me3 increase for all these patient groups.